文献速递流行病学与生物统计临床试验与 GCP

混合对照组增强随机对照试验分析中的混杂调整

Confounding adjustment in the analysis of augmented randomized controlled trial with hybrid control arm.
PubMed 文献 · Stat Med · 2023-04-25

针对包含随机治疗组、较小随机对照组和大型合成对照组的增强随机对照试验,提出用倾向性评分分析平衡合成对照组与随机对照组间的已观测混杂因素,并估计和检验未观测混杂所致偏倚。进一步提出部分偏倚校正程序以减少未观测混杂偏倚。大量模拟研究显示该程序能有效整合合成对照组,提高效率和统计功效,同时控制估计偏倚和I类错误膨胀,并用肿瘤学增强随机对照试验数据作了说明。

要点

  • 增强随机对照试验中合成对照组与随机对照组的已观测混杂因素可用倾向性评分平衡。
  • 未观测混杂所致偏倚可通过分析两对照组倾向性评分调整后的结局来估计和检验。
  • 部分偏倚校正程序可减少未观测混杂偏倚,模拟研究显示能提高效率和统计功效。

核心结论

  • 提出的倾向性评分加部分偏倚校正程序可在整合合成对照组数据时提高效率和统计功效,同时控制未观测混杂可能引起的估计偏倚和I类错误膨胀。

研究设计与样本

  • 方法学研究,提出倾向性评分分析与部分偏倚校正程序,并用大量模拟研究和一项肿瘤学增强随机对照试验数据说明。
  • 增强随机对照试验包含随机治疗组、较小的随机对照组和来自真实世界数据的大型合成对照组。

主要发现

  • 合成对照组与随机对照组在已观测和未观测混杂因素分布上可能存在系统性差异,两者一起作为混合对照分析时可导致偏倚。
  • 倾向性评分分析可平衡合成对照组与随机对照组间的已观测混杂因素。
  • 通过分析合成对照组与随机对照组倾向性评分调整后的结局,可估计和检验未观测混杂所致的可能偏倚。
  • 部分偏倚校正程序可减少未观测混杂所致偏倚。
  • 大量模拟研究显示,倾向性评分加部分偏倚校正程序能有效整合合成对照组,提高效率和统计功效,同时控制估计偏倚和I类错误膨胀。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The augmented randomized controlled trial (RCT) with hybrid control arm includes a randomized treatment group (RT), a smaller randomized control group (RC), and a large synthetic control (SC) group from real-world data. This kind of trial is useful when there is logistics and ethics hurdle to conduct a fully powered RCT with equal allocation, or when it is necessary to increase the power of the RCT by incorporating real-world data. A difficulty in the analysis of augmented RCT is that the SC and RC may be systematically different in the distribution of observed and unmeasured confounding factors, causing bias when the two control groups are analyzed together as hybrid controls. We propose to use propensity score (PS) analysis to balance the observed confounders between SC and RC. The possible bias caused by unmeasured confounders can be estimated and tested by analyzing propensity score adjusted outcomes from SC and RC. We also propose a partial bias correction (PBC) procedure to reduce bias from unmeasured confounding. Extensive simulation studies show that the proposed PS + PBC procedures can improve the efficiency and statistical power by effectively incorporating the SC into the RCT data analysis, while still control the estimation bias and Type I error inflation that might arise from unmeasured confounding. We illustrate the proposed statistical procedures with data from an augmented RCT in oncology.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Li L, Jemielita T. Confounding adjustment in the analysis of augmented randomized controlled trial with hybrid control arm. Stat Med. 2023. PMID: 37186394. doi:10.1002/sim.9753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。